“Research-based, health for people” is Merck’s values ??and code of conduct. Merck adheres to lofty professional ethics, is committed to high-quality professional services, and brings the most valuable medicines to patients through excellent management. Although our business is to develop and promote new drugs and vaccines, we always believe that improving human health and improving the quality of people's lives is Merck's mission, and we are passionate about it. Like everyone else, we all want to be healthier and live longer.
We are very excited to be able to witness China's comprehensive development, participate in China's great medical reform cause, and contribute scientific research and services. Our commitment to China is consistent: we will continue to work closely with the Chinese government, medical institutions, scientists and medical staff, commit ourselves to improving the health and quality of life of the Chinese people, and make unremitting efforts for the development of China’s health industry!
Merck reached a technology transfer licensing agreement with the Chinese government in 1989 to transfer to China the most advanced genetically engineered hepatitis B vaccine production technology at the time. Since 1994, more than 200 million Chinese children have been effectively protected.
In 1992, Merck Group officially established Merck (China) Co., Ltd.
In 1994, Merck and Hangzhou Huadong Pharmaceutical Group established a joint venture - Hangzhou Merck Pharmaceutical Co., Ltd. The joint venture factory is built on Moganshan Road, Hangzhou, covering an area of ??more than 12,000 square meters. (Welcome to visit MSD factory in Hangzhou)
In order to support the Chinese government in better carrying out AIDS prevention and treatment work through international cooperation, MSD and the Chinese Ministry of Health signed a memorandum of understanding on the comprehensive AIDS prevention and treatment cooperation project in May 2005.
Diversified products
Currently, we provide products in China covering cardiovascular, anti-infection, men’s health, women’s health, orthopedics, pain, skin, respiratory, diabetes, specialty drugs, and auxiliary products. 42 kinds of human medicines and vaccines in reproductive and other fields. We also provide 46 types of animal health products to the Chinese market to prevent and treat diseases of poultry, livestock and pets.
Promote scientific research information and promote academic exchanges
Merck Books: Both medical workers, patients and consumers have the need to obtain comprehensive, reliable and credible medical and health information . Therefore, Merck has translated and published a series of its professional medical reference books in China, including the "Merck Manual of Diagnosis and Treatment" known as the "Doctor's Bible", as well as the "Merck Manual of Geriatrics", "Merck Index", etc. In 1999, the Chinese version of the Merck Family Diagnosis and Treatment Manual was launched for the general public. Now you can also browse these books online on this website.
Online continuing education: Merck provides Chinese medical staff with a free online continuing education website "Meiweida", which provides a free three-dimensional medical illustration library, free downloads of expert presentations, and international There are Chinese abstracts of articles in the top medical journal "The Lancet", and there is an online learning module of the British Medical Journal. All of this is completely free and aims to provide doctors in China with a higher level of continuing medical education so that it can ultimately benefit the majority of patients.
Academic exchange: Merck actively supports medical exchanges and the reform of the medical security system in China, and has funded and prepared a series of international seminars, such as the Symposium on Contemporary Challenges of Infectious Diseases, Hypertension, High Lipidemia seminar, osteoporosis seminar, international health care trend news seminar and international medical insurance seminar, etc.
Promote research: Merck also spares no effort in promoting continuing education and scientific research: for example, in 1995, it established the "Urology Training Center" in China, created the "Merck Scientific Research Fund", and promoted the "Merck International Clinical Pharmacology Scholarship" Activities etc.
Growing
Merck is still growing in China. It currently has more than 5,100 employees, 19 offices and 3 production plants across the country. Business personnel are distributed in 120 cities across the country.